Evaluation of health utility in trial-based cost–utility analyses for major cardiovascular disease: protocol for a systematic review
Introduction The global incidence of cardiovascular disease (CVD) is high, and the medical costs associated with its management have been increasing. Cost–utility analyses (CUAs) are essential for understanding the value of healthcare interventions and for decision-making. A majority of the CUAs for...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/5/e067045.full |